Dopamine Dysregulation in Parkinson’s Disease and Substance Use: Therapeutic Use and Compulsive Behaviors Thin Line
Objective: Parkinson's Disease (PD) inherently disrupts dopaminergic transmission, primarily within the nigrostriatal pathway, necessitating dopaminergic therapies. However, these therapies can lead to Dopamine Dysregulation Syndrome…Two unusual cases of dopamine dysregulation syndrome in patients with Parkinson’s disease
Objective: To present two cases of dopamine dysregulation syndrome (DDS) in patients with Parkinson’s disease (PD) who took extreme measures to access more dopaminergic medication.…Dopamine Dysregulation Syndrome Outcomes following Pallidal Deep Brain Stimulation in Parkinson’s Disease
Objective: To examine the impact of pallidal deep brain stimulation (DBS) on symptoms of Dopamine Dysregulation Syndrome (DDS) in Parkinson’s disease (PD). Background: DDS is…Impulse Control Disorder and medication management in Patients with Early-Onset Parkinson’s Disease
Objective: To assess the usage frequency of dopamine agonists (DA), the prevalence of impulse control disorder (ICD) in patients with Early-onset Parkinson’s Disease (EOPD), and…Dopamine dysregulation syndrome in Parkinson’s disease controlled by safinamine
Objective: To describe a case of dopamine dysregulation syndrome managed by safinamide. Background: Dopamine dysregulation syndrome (DDS) is an uncommon non-motor symptom of Parkinson disease…Predictors of relapse in impulse control disorders in patients with Parkinson’s disease.
Objective: Identify predictors of relapse in impulse control disorders (ICD) in patients with Parkinson's disease. Background: Behaviors that are performed repeatedly, excessively or minimally and…Apathy Following Bilateral Subthalamic Deep Brain Stimulation for Parkinson’s Disease: The INTREPID Randomized Controlled Trial
Objective: To determine frequency and predictors of improvement or worsening of apathy in participants receiving bilateral subthalamic deep brain stimulation (STN-DBS) for the treatment of…Dopamine dysregulation syndrome in Parkinson’s disease after COVID-19. Case report.
Objective: To describe a case of a man with Parkinson’s disease (PD), who was developed dopamine dysregulation syndrome (DDS) after COVID-19. Background: Parkinson’s disease is…Sex-specific neuroprotection by inhibition of the Y-chromosome gene, SRY, in experimental Parkinson’s disease
Objective: Given the presence and function of SRY in male DA (dopamine) neurons, we hypothesised that dysregulation of SRY may contribute to male susceptibility to…Maladaptive use of LD/CD tablets as painkillers causing Dopamine Dysregulation Syndrome in 4 patients of Advanced Parkinson’s Disease
Objective: To study four cases of maladaptive use of levodopa/carbidopa (LD/CD) as painkillers causing Dopamine dysregulation syndrome (DDS) in Parkinson’s disease (PD) patient in a…
- 1
- 2
- 3
- …
- 5
- Next Page »